Core Viewpoint - The article discusses the impact of geopolitical tensions in the Middle East and the closure of the Strait of Hormuz on the prices of various chemical raw materials, particularly vitamins and amino acids, leading to a significant tightening of supply and rising prices in the market [1]. Supply and Demand Analysis - The supply of vitamins and amino acids has been significantly tightened, with traders reporting that manufacturers are not shipping products, particularly popular varieties like Vitamin A and E [1]. - The current price surge has benefited producers and traders across the industry chain, although opinions on future price trends are divided [1]. Price Trends - The price increase for vitamins and amino acids began at the end of February and has continued for nearly a month, with various products experiencing different degrees of price rises [2]. - As of March 23, Vitamin E was priced at 89 RMB/kg, up 7.23% in the past week, while Vitamin A reached 101.71 RMB/kg, with a weekly increase of 15.96% [2]. - The price of imported methionine rose by 47.79% to 50.25 RMB/kg, and domestic methionine increased by 49.62% to 49 RMB/kg [2]. Inventory and Sales Dynamics - Traders have reported that their inventory has appreciated in value due to rising prices, with many holding back on sales to maximize profits [3]. - Despite the price increases, sales volumes have not shown significant changes compared to previous periods, with some traders indicating that demand is stable but not dramatically increasing [3][4]. Manufacturer Behavior - There are reports of manufacturers withholding stock, with many citing "force majeure" as a reason for halting supplies, leading to a situation where traders have limited access to products [4].

Core Viewpoint - The article discusses the shift in consumer sentiment in the AI era, emphasizing the need for transparency and trust in business practices, particularly in the health supplement industry. Brands that adopt a transparent and altruistic approach are likely to gain customer loyalty and competitive advantage [2][3]. Group 1: Consumer Sentiment and Business Strategy - In the AI era, consumers are increasingly anxious about being misled or overcharged, leading to a demand for transparency in pricing and product quality [2][3]. - Businesses must adapt their strategies from exploiting information asymmetry to building trust through transparent practices, such as openly sharing costs and product details [2][3]. - Brands like Pang Donglai and Nutrition Factory exemplify this shift by prioritizing customer trust and loyalty through transparent pricing and high-quality products [2][3][6]. Group 2: Transparency as a Business Strategy - Transparency involves clearly communicating the costs associated with raw materials, production, and other expenses to consumers [3][4]. - For example, a product's total cost breakdown includes factory costs, taxes, shipping, and service fees, which can be presented to consumers to eliminate doubts about pricing [4][6]. - This level of transparency is particularly appealing to consumers who want to avoid being taken advantage of, especially in the health supplement market [6][7]. Group 3: Quality Assurance - Quality is paramount; transparency alone is insufficient if the product quality does not meet consumer expectations [8][9]. - Nutrition Factory focuses on sourcing high-quality ingredients and collaborating with reputable suppliers to ensure product safety and efficacy [8][9]. - The company invests in research and development, partnering with academic institutions to validate the effectiveness of its products [9][10]. Group 4: Competitive Pricing and Market Positioning - Nutrition Factory offers products at significantly lower prices compared to competitors while maintaining high quality, which is achieved by cutting out middlemen and celebrity endorsements [7][14]. - The company's pricing strategy is designed to attract consumers who are price-sensitive yet quality-conscious, leading to high customer retention and referral rates [14][15]. - By leveraging cost savings from efficient supply chain management, Nutrition Factory can provide substantial discounts and promotional offers, further enhancing its market position [15][16]. Group 5: Challenges and Industry Dynamics - Despite the apparent simplicity of the altruistic strategy, it is challenging to implement due to existing commercial practices that favor quick gains through marketing and celebrity endorsements [15]. - Maintaining a commitment to transparency and quality requires a long-term vision and the ability to resist short-term profit temptations [15]. - The article suggests that while many may attempt to replicate the transparent model, true success lies in the genuine commitment to consumer welfare and product integrity [15].

Group 1 - The stock price of Huayuan Bio (300401) experienced significant fluctuations in the past week, with a peak increase of 5.98% on February 6, closing at 19.15 yuan, and a total market value of 95.65 billion yuan as of February 12 [1] - The stock showed a trading range of 12.45% and a high turnover rate, indicating active trading, with a net outflow of 39.57 million yuan from institutional investors and a net inflow of 39.57 million yuan from retail investors on February 12 [1] Group 2 - Huayuan Bio is recognized as a leader in the vitamin segment and has gained market attention as a hot stock in the chemical sector, with significant holdings by Southern Fund's CSI 1000 ETF, which owns 347.85 thousand shares (0.65% of circulating shares) but reduced its holdings by 48.4 thousand shares in the third quarter [2] - The chemical sector, particularly phosphates and vitamins, has been driven by policy and demand, with Huayuan Bio being highlighted for its vitamin D3 supply chain [2] Group 3 - Institutional ratings for Huayuan Bio are generally neutral, with a target price of 22.00 yuan, indicating a potential upside of 21.48% from the latest price [3] - The forecast for net profit growth is modest, with a projected increase of 0.18% for 2025 and a more substantial growth of 40.35% expected in 2026, while the current price-to-earnings ratio (TTM) stands at 31.69 [3] - The proportion of institutional holdings is relatively low at 0.11%, and the frequency of institutional research is average [3]

Group 1 - Garden Biologics experienced a decline of 5.22% on February 9, with a stock price of 18.15 yuan per share and a trading volume of 585 million yuan, resulting in a turnover rate of 5.88% and a total market capitalization of 9.864 billion yuan [1] - The company, Zhejiang Garden Biologics Co., Ltd., was established on December 18, 2000, and went public on October 9, 2014. Its main business focuses on developing, producing, and selling products related to a complete vitamin D3 industry chain [1] - The revenue composition of the company includes vitamin products at 47.41%, pharmaceuticals at 30.22%, lanolin and its derivatives at 20.93%, sales of raw materials and others at 1.01%, rental income at 0.31%, other trade products at 0.10%, and medical devices at 0.01% [1] Group 2 - Among the top circulating shareholders of Garden Biologics, a fund under Southern Fund holds a position. The Southern CSI 1000 ETF (512100) reduced its holdings by 48,400 shares in the third quarter, now holding 3.4785 million shares, which accounts for 0.65% of the circulating shares [2] - The estimated floating loss for the Southern CSI 1000 ETF (512100) today is approximately 3.4785 million yuan. The fund was established on September 29, 2016, with a latest scale of 78.996 billion yuan, and has achieved a 6% return this year, ranking 1533 out of 5580 in its category [2] - The fund manager, Cui Lei, has a tenure of 7 years and 96 days, with a total fund asset size of 137.02 billion yuan. The best fund return during the tenure is 279.97%, while the worst return is -15.93% [2]

Core Viewpoint - The recent trend of "eating sun-exposed mushrooms can supplement vitamin D" is validated by scientific research, highlighting the significant increase in vitamin D2 content in mushrooms when exposed to sunlight or artificial UV light, which can enhance bone health [1] Group 1: Vitamin D and Health Implications - Vitamin D deficiency can lead to osteoporosis and increased fracture risk, particularly in winter when sunlight exposure is limited, affecting calcium absorption and utilization [2] - Research indicates that low vitamin D levels not only increase fracture risk but also prolong healing time, with winter conditions exacerbating the risk of falls and fractures, especially among the elderly [2] Group 2: Current Vitamin D Intake in China - A national survey from 2017-2018 revealed that about one-third of the population is "deficient" in vitamin D, with even higher rates of "insufficiency," particularly in northern regions and among women and urban residents [3] - Monitoring results show that over 60% of adolescents and children are either "deficient" or "insufficient" in vitamin D, with southern youth faring slightly better than those in the north [3] Group 3: Practical Tips for Vitamin D Supplementation in Winter - It is recommended to consume foods rich in vitamin D, such as fatty fish, liver, and egg yolks, although dietary intake is often insufficient [4] - Sun exposure is crucial, with optimal times being between 11:00 AM and 2:00 PM, and exposing larger skin areas like limbs is more effective for vitamin D synthesis [4] - Avoiding barriers to UV exposure, such as staying indoors or using sunscreen, is essential for maximizing vitamin D production from sunlight [5] - Vitamin D supplements, particularly vitamin D3, are advised during winter, with dosage consultation recommended and follow-up blood tests suggested to monitor levels [5][6] - Additionally, fortified foods like vitamin D-enriched milk and bread can be included in the diet to enhance vitamin D intake [6]

Market Performance - The new materials sector experienced a decline this week, with the new materials index falling by 5.29%, underperforming the ChiNext index which decreased by 5.19% [1][4] - Over the past five trading days, the synthetic biology index dropped by 3.13%, semiconductor materials by 3.60%, electronic chemicals by 3.77%, biodegradable plastics by 0.90%, industrial gases by 3.96%, and battery chemicals by 4.89% [1][9] Price Tracking - Amino acids prices showed the following changes: valine remained at 14,050 CNY/ton, arginine increased by 2.64% to 21,400 CNY/ton, tryptophan rose by 1.27% to 31,900 CNY/ton, and methionine increased by 2.82% to 18,200 CNY/ton [2] - Prices for biodegradable materials remained stable, with PLA (FY201 injection grade) at 17,800 CNY/ton and PBS at 17,000 CNY/ton [2] - Vitamin A decreased by 1.60% to 61,500 CNY/ton, while other vitamins remained unchanged [2] Investment Recommendations - SpaceX plans to establish a satellite constellation of up to 1 million satellites, significantly increasing demand for upstream raw materials, particularly lightweight and cable materials [3] - Companies to watch in lightweight materials include Times New Material, Jilin Chemical Fiber, Zhongfu Shenying, Guangwei Composites, and Heshun Technology; for cable materials, focus on Pulit and Panyam Micro透 [3]

Group 1: Chemical Sector Performance - The chemical raw materials index increased by 1.10%, while the chemical machinery index rose by 2.87%. However, the chemical pharmaceuticals index decreased by 1.41%, and the pesticide and fertilizer index increased by 2.99% [1] - The top five rising petrochemical products included liquid chlorine, which surged by 92.93%, industrial-grade lithium carbonate, which rose by 25.75%, and propylene oxide, which increased by 8.84% [1] - The top five declining petrochemical products included vitamin D3, which fell by 4.17%, methyl acrylate, which decreased by 3.92%, and nitric acid, which dropped by 2.51% [1] Group 2: Oil Sector Performance - The oil processing index decreased by 3.66%, and the oil extraction index fell by 0.36%, while the oil trading index increased by 4.17% [1] - As of January 16, the settlement price for West Texas Intermediate crude oil was $59.44 per barrel, up 0.54% from January 9, and the settlement price for Brent crude oil was $64.13 per barrel, up 1.25% from January 9 [1] Group 3: Listed Chemical Companies - The top five rising listed chemical companies included Bofei Electric, which increased by 61.06%, Qicai Chemical, which rose by 27.94%, and Aladdin, which gained 20.24% [2] - The top five declining listed chemical companies included Zaiseng Technology, which fell by 26.65%, ST Jiaao, which decreased by 18.42%, and Pulit, which dropped by 17.28% [2]

Group 1: Chemical Sector Performance - The chemical index outperformed the oil index last week, with all chemical indices rising. The chemical raw materials index increased by 5.14%, the chemical machinery index rose by 7.20%, the chemical pharmaceuticals index climbed by 7.33%, and the pesticide and fertilizer index went up by 5.10% [1] - In the oil sector, the oil processing index increased by 0.65%, while the oil extraction index fell by 3.82%, and the oil trading index rose by 4.88% [1] Group 2: Oil Price Movements - International crude oil prices showed mixed trends. As of January 9, the settlement price for West Texas Intermediate (WTI) crude oil was $59.12 per barrel, up 3.14% from January 2. The settlement price for Brent crude oil was $63.34 per barrel, up 4.26% from January 2 [1] Group 3: Petrochemical Product Price Changes - The top five petrochemical products with the highest price increases were battery-grade lithium carbonate (up 18.21%), butadiene (up 10.37%), isooctyl acrylate (up 8.23%), diethylene glycol (up 5.90%), and polybutadiene rubber (up 4.86%). The top five products with the largest price declines were liquid chlorine (down 31.25%), glycine (down 4.55%), vitamin D3 (down 4.00%), mancozeb (down 3.45%), and acrylonitrile (down 3.33%) [1] Group 4: Capital Market Performance of Listed Chemical Companies - The top five listed chemical companies with the highest stock price increases were Puli Tech (up 42.59%), Dawi Technology (up 35.34%), Sanfu Co. (up 32.29%), Guofeng Plastics (up 30.63%), and Tongcheng New Materials (up 30.54%). The bottom five companies with the largest stock price declines were Evergrande High-tech (down 13.05%), Jiabiyou (down 12.16%), Hangzhou High-tech (down 11.24%), Yahua Group (down 6.59%), and Fengshen Co. (down 5.48%) [2]

Core Viewpoint - Garden Bio has received approval from the Ministry of Agriculture and Rural Affairs for its cholesterol derived from lanolin as a new feed additive, which is expected to enhance its product application areas and core competitiveness [1][2][3] Group 1: Product Approval and Market Potential - Cholesterol derived from lanolin has been approved as a new feed additive for shrimp, with a recommended addition rate of 1.0-2.0g/kg in feed and a maximum limit of 10g/kg [1] - The total industrial feed production in China is projected to reach 31,503.1 million tons in 2024, with aquaculture feed accounting for approximately 2,262 million tons, representing 7.18% of the total feed production [1] Group 2: Company Overview and Production Capacity - Garden Bio is primarily engaged in the research, production, and sales of vitamin D3 and A series products, with a focus on lanolin cholesterol, vitamin D3, and 25-hydroxy vitamin D3 [2] - The company has established itself as a global leader in the vitamin D3 production chain, with an annual production capacity of 3,600 tons, making it one of the largest vitamin D3 producers globally [3] - The annual production of NF-grade cholesterol is 1,200 tons, accounting for over half of the global capacity [3] Group 3: Financial Performance - In the first half of 2025, Garden Bio reported a revenue of 635 million yuan, with vitamin products contributing 301 million yuan and lanolin and its derivatives generating 133 million yuan [3] Group 4: Future Outlook - The approval of the new feed additive certificate is expected to create favorable conditions for the company's stable development and will be followed by compliance with relevant laws and regulations in production and sales [3]

Group 1: Chemical Sector Performance - The chemical sector indices experienced declines, with the chemical raw materials index down by 0.65%, chemical machinery index down by 2.97%, pharmaceutical index down by 2.19%, and pesticide and fertilizer index down by 0.73% [1] - In contrast, the oil sector indices showed positive performance, with the oil processing index up by 6.19%, oil extraction index up by 4.93%, and oil trading index up by 2.66% [1] Group 2: Oil Price Movements - International crude oil prices showed a strong fluctuation, with WTI settling at $57.32 per barrel, an increase of 1.02% from December 26, 2025, and Brent settling at $60.75 per barrel, an increase of 0.18% [1] Group 3: Petrochemical Product Price Changes - The top five petrochemical products with price increases included industrial-grade lithium carbonate up by 22.37%, purified terephthalic acid up by 8.32%, paraxylene (CFR China) up by 6.97%, polyester FDY up by 5.04%, and shale oil up by 4.98% [1] - The top five petrochemical products with price declines included liquid chlorine down by 37.72%, liquefied natural gas down by 6.69%, pure MDI down by 4.23%, sulfur down by 3.96%, and vitamin D3 down by 3.85% [1] Group 4: Capital Market Performance of Chemical Companies - The top five performing listed chemical companies included Guoli Technology up by 20.18%, Heshun Technology up by 19.11%, Longgao Co. up by 18.91%, Shuangwei New Materials up by 15.68%, and Cangzhou Dahua up by 14.56% [2] - The bottom five performing listed chemical companies included Qingshuiyuan down by 12.54%, Shilong Industrial down by 11.51%, Ruihua Tai down by 10.92%, Monte High-tech down by 10.21%, and Kaisheng New Materials down by 9.80% [2]